Retroviral transduction of peptide stimulated t cells can generate dual t cell receptor-expressing (bifunctional) t cells reactive with two defined antigens

Journal of Translational Medicine

Volumn 2, Issue , 2004, Pages

  Langerman, Alexander ^a,b   Callender, Glenda G ^a   Nishimura, Michael I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; HLA A2 ANTIGEN; MELAN A; MELANOMA ANTIGEN; RETROVIRUS VECTOR; T LYMPHOCYTE RECEPTOR; TETRAMER;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER; CONTROLLED STUDY; DISEASE COURSE; DONOR; GENETIC CODE; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INCUBATION TIME; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN TARGETING; T LYMPHOCYTE ACTIVATION; TUMOR CELL; VIRUS INFECTION;

EID: 18144368144     PISSN: 14795876     EISSN: None     Source Type: Journal    
DOI: 10.1186/1479-5876-2-42     Document Type: Article

References (23)

1. Real LM, Jimenez P, Kirkin A, Serrano A, Garcia A, Zeuthen J, Garrido F, Ruiz-Cabello F: Multiple mechanisms of immune invasion can co-exist in melanoma tumor lines derived from the same patient. Ca Immunol Immunother 2001, 49:621-628.
2. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL: Viral subversion of the immune system. Annu Rev Immunol 2000, 18:861-926.
3. Khong HT, Wang QJ, Rosenberg SA: Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression. J Immunother 2004, 27(3):184-190.
4. Kaplan BLF, Yu DC, Clay TM, Nishimura MI: Redirecting T lymphocyte specificity using T cell receptor genes. Intern Rev Immunol 2003, 22:229-253.
5. Heemskerk MHM, Hoogeboom M, Hagedoorn R, Kester MGD, Willemze R, Falkenburg JHF: Reprogramming of virus-specific T cells into Leukemia-reactive T cells using T cell receptor gene transfer. J Exp Med 2004, 199(7):885-894.
6. Nishimura MI, Avichezer D, Custer MC, Lee CS, Chen C, Parkhurst MR, Diamond RA, Robbins PF, Schwartzentruber DJ, Rosenberg SA: MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte. Cancer Res 1999, 59(24): 6230-6238.
7. Clay TM, Custer MC, Sachs J, Hwu P, Rosenberg SA, Nishimura MI: Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J Immunol 1999, 163:507-513.
8. Lamers CHJ, Willemsen RA, Luider BA, Debets R, Bolhuis RLH: Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer. Ca Gene Ther 2002, 9:613-623.
9. Dudley ME, Wunderlich J, Nishimura MI, Yu D, Yang JC, Topalian SL, Schwartzentruber DJ, Hwu P, Marincola FM, Sherry R, Leitman SF, Rosenberg SA: Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother 2001, 24:263.
10. Kozak M: The scanning model for translation: an update. J Cell Biol 1989, 108:229-241.
11. Roszkowski JJ, Yu DC, Rubinstein MP, McKee MD, Cole DJ, Nishimura MI: CD8-independent tumor cell recognition is a property of the T cell receptor and no the T cell. J Immunol 2003, 170: 2582-9.
12. Morgan RA, Dudley ME, Yu YYL, Zheng Z, Robbins PF, Theoret MR, Wunderlich JR, Hughes MS, Restifo NP, Rosenberg SA: High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens. J Immunol 2003,171:3287-3295.
13. Fossati G, Cooke A, Papafio RQ, Haskins K, Stockinger B: Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes. J Exp Med 1999, 4:577-583.
14. Kong YY, Eto M, Omoto K, Umesue M, Hashimoto A, Nomoto K: Regulatory T cells in maintenance and reversal of peripheral tolerance in vivo. J Immunol 1996, 157(12):5284-5289.
15. Hinz T, Weidmann E, Kabelitz D: Dual TCR-expressing T lymphocytes in health and disease. Int Arch Allergy Immunol 2001, 125:16-20.
16. Stanislawski TR, Voss H, Lotz C, Sadovnikoka E, Willemsen RA, Kuball J, Ruppert T, Bolhuis RL, Melief CJ, Huber C, Strauss HJ, Theobald M: Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol 2001, 2(10):962-970.
17. Wu Y, Liu Y: Viral induction of co-stimulatory activity on antigen-presenting cells bypasses the need for CD4+ T cell help in CD8+ T cell responses. Curr Biol 1994, 4:499-505.
18. Haanen JBAG, Toebes M, Cordaro TA, Wolkers MC, Kruisbeek AM, Schumacher TNM: Systemic T cell expansion during localized viral infection. Eur J Immunol 1999, 29:1168-1174.
19. Kershaw MH, Westwood JA, Hwu P: Dual-specific T cells combine proliferation and antitumor activity. Nat Biotechnol 2002, 20:1221-1227.
20. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Scwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA: Cancer regression and autoimmunity in patients after clonal repopulation antitumor lymphocytes. Science 2002, 298:850-854.
21. Englehard VH, Bullock TN, Collela TA, Sheasley SL, Mullins DW: Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol Rev 2002, 188:136-46.
22. Rosenberg SA: Effective immunotherapy for cancer patients. J Am Coll Surg 2004, 198(5):685-696.
23. Morgan RA, Dudley ME, Yu YYL, Zheng Z, Robbins PF, Theoret MR, Wunderlich JR, Hughes MS, Restifo NP, Rosenberg SA: High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens. J Immunol 2003, 171:3287-3295.